Decibel Therapeutics to Participate in the Upcoming Jefferies Healthcare Conference
June 02 2023 - 7:00AM
Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology
company dedicated to discovering and developing transformative
treatments to restore and improve hearing and balance, today
announced that Laurence Reid, Ph.D., Chief Executive Officer, will
present a corporate overview at the Jefferies Healthcare Conference
on Friday, June 9, 2023 at 12:45 p.m. E.T in New York, NY.
A live webcast of the presentation may be accessed by visiting
the Investors section of the Decibel Therapeutics website at
https://ir.decibeltx.com. An archived replay of the webcast will be
available on the Company’s website for approximately 90 days
following the fireside chat.
About Decibel Therapeutics
Decibel Therapeutics is a clinical-stage biotechnology company
dedicated to discovering and developing transformative treatments
to restore and improve hearing and balance, one of the largest
areas of unmet need in medicine. Decibel has built a proprietary
platform that integrates single-cell genomics and bioinformatic
analyses, precision gene therapy technologies and expertise in
inner ear biology. Decibel is leveraging its platform to advance
gene therapies designed to selectively replace genes for the
treatment of congenital, monogenic hearing loss and to regenerate
inner ear hair cells for the treatment of acquired hearing and
balance disorders. Decibel’s pipeline, including its lead gene
therapy program, DB-OTO, to treat congenital, monogenic hearing
loss, is designed to deliver on our vision of a world in which the
privileges of hearing and balance are available to all. For more
information about Decibel Therapeutics, please visit
www.decibeltx.com or follow us on Twitter.
Investor Contact:Julie SeidelStern Investor
Relations, Inc.julie.seidel@sternir.com212-362-1200
Media Contact:Chris RaileyTen Bridge
CommunicationsChris@tenbridgecommunications.com617-834-0936
Decibel Therapeutics (NASDAQ:DBTX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Decibel Therapeutics (NASDAQ:DBTX)
Historical Stock Chart
From Jul 2023 to Jul 2024